JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHA:600200)
China · Delayed Price · Currency is CNY 1.880
-0.100 (-5.05%)
Jul 18, 2025, 9:44 AM CST
SHA:600200 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -4.89 | 70.48 | -71.95 | -76.27 | 22.72 | -506.41 | Upgrade |
Depreciation & Amortization | 49.74 | 49.74 | 45.89 | 47.63 | 49.75 | 83.44 | Upgrade |
Other Amortization | 2.3 | 2.3 | 1.64 | 1.66 | 1.61 | 4.27 | Upgrade |
Loss (Gain) From Sale of Assets | 0.14 | 0.14 | 0.89 | -0.16 | -105.02 | 296.16 | Upgrade |
Asset Writedown & Restructuring Costs | 0.8 | 0.8 | - | - | - | 60.18 | Upgrade |
Loss (Gain) From Sale of Investments | -11.63 | -11.63 | -29.17 | -12.09 | -18.26 | -16.25 | Upgrade |
Provision & Write-off of Bad Debts | 2.61 | 2.61 | 0.85 | -1.36 | 1.38 | 33.42 | Upgrade |
Other Operating Activities | -766.29 | 88.8 | 76.23 | 74.52 | 62.89 | 82.6 | Upgrade |
Change in Accounts Receivable | -70.35 | -70.35 | -257.34 | -169.24 | 395.79 | -1,922 | Upgrade |
Change in Inventory | 9.77 | 9.77 | 3.23 | 12.31 | 24.78 | 59.3 | Upgrade |
Change in Accounts Payable | -394.13 | -394.13 | 18.07 | 166 | 12.95 | 1,409 | Upgrade |
Change in Other Net Operating Assets | 3.47 | 3.47 | 8.1 | 12.61 | - | 1.16 | Upgrade |
Operating Cash Flow | -1,205 | -274.65 | -203.68 | 56.27 | 447.64 | -414.56 | Upgrade |
Operating Cash Flow Growth | - | - | - | -87.43% | - | - | Upgrade |
Capital Expenditures | -31.89 | -35.31 | -82.58 | -41.72 | -24.81 | -44.25 | Upgrade |
Sale of Property, Plant & Equipment | 1.19 | 0.65 | 0.23 | 0.95 | 67.37 | 58.18 | Upgrade |
Cash Acquisitions | -120.98 | -120.98 | - | - | -8.5 | - | Upgrade |
Divestitures | - | - | - | - | - | 14.08 | Upgrade |
Investment in Securities | 76.45 | -27.72 | 388.2 | -112.52 | -125.6 | 130.5 | Upgrade |
Other Investing Activities | 2.72 | 13.14 | 53.05 | 214.62 | 134.8 | 77.18 | Upgrade |
Investing Cash Flow | -72.53 | -170.23 | 358.9 | 61.34 | 43.27 | 235.69 | Upgrade |
Long-Term Debt Issued | - | 1,084 | 1,855 | 1,355 | 1,438 | 1,769 | Upgrade |
Long-Term Debt Repaid | - | -1,215 | -1,936 | -1,087 | -1,396 | -1,485 | Upgrade |
Net Debt Issued (Repaid) | -192.66 | -131.17 | -80.71 | 268.22 | 42.25 | 284.5 | Upgrade |
Issuance of Common Stock | - | - | - | 28.6 | - | - | Upgrade |
Repurchase of Common Stock | -0.49 | -0.49 | -0.14 | - | - | - | Upgrade |
Common Dividends Paid | -62.39 | -67.8 | -67.86 | -71.2 | -62.49 | -62.75 | Upgrade |
Other Financing Activities | 67.37 | 143.04 | 272.55 | -110.89 | -25.6 | 14.12 | Upgrade |
Financing Cash Flow | -188.17 | -56.41 | 123.85 | 114.74 | -45.84 | 235.87 | Upgrade |
Foreign Exchange Rate Adjustments | 0.35 | 0.35 | -0.13 | -0.15 | -0 | -0.01 | Upgrade |
Net Cash Flow | -1,465 | -500.93 | 278.94 | 232.2 | 445.07 | 57 | Upgrade |
Free Cash Flow | -1,237 | -309.96 | -286.26 | 14.55 | 422.83 | -458.81 | Upgrade |
Free Cash Flow Growth | - | - | - | -96.56% | - | - | Upgrade |
Free Cash Flow Margin | -83.01% | -19.39% | -12.78% | 0.72% | 23.82% | -24.51% | Upgrade |
Free Cash Flow Per Share | -1.75 | -0.43 | -0.40 | 0.02 | 0.60 | -0.64 | Upgrade |
Cash Income Tax Paid | 110.37 | 103.13 | 96.38 | 91.22 | 91.09 | 94.64 | Upgrade |
Levered Free Cash Flow | -1,575 | -674.25 | 2.17 | 189.72 | 444.92 | -772.61 | Upgrade |
Unlevered Free Cash Flow | -1,534 | -629.36 | 49.88 | 236.35 | 485.27 | -732.35 | Upgrade |
Change in Net Working Capital | 1,568 | 714.23 | -96.75 | -233.86 | -489.18 | 728.57 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.